KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Financing Activities (2016 - 2025)

Bausch Health Companies' Cash from Financing Activities history spans 17 years, with the latest figure at -$235.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 376.47% year-over-year to -$235.0 million; the TTM value through Dec 2025 reached -$742.0 million, up 14.52%, while the annual FY2025 figure was -$742.0 million, 14.52% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$235.0 million at Bausch Health Companies, up from -$719.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.8 billion in Q3 2023 and bottomed at -$1.2 billion in Q3 2021.
  • The 5-year median for Cash from Financing Activities is -$167.5 million (2024), against an average of -$106.1 million.
  • The largest annual shift saw Cash from Financing Activities tumbled 888.89% in 2021 before it skyrocketed 5144.44% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $275.0 million in 2021, then plummeted by 200.36% to -$276.0 million in 2022, then soared by 71.38% to -$79.0 million in 2023, then skyrocketed by 207.59% to $85.0 million in 2024, then tumbled by 376.47% to -$235.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Cash from Financing Activities are -$235.0 million (Q4 2025), -$719.0 million (Q3 2025), and $358.0 million (Q2 2025).